Related by context. All words. (Click for frequent words.) 63 Xl Capital Ltd 61 PEGylated interferon 60 Xanafide 60 bile acid sequestrant 59 samalizumab 59 pharmacodynamic profile 59 Belerofon 59 somatostatin analog 59 immunofluorescence staining 59 vidofludimus 59 somatostatin analogues 59 oral treprostinil 59 Platinol ® 59 liposomal formulation 59 pharmacodynamic PD 58 evaluating tivozanib 58 Melphalan 58 PEG IFN 58 sublingual formulation 58 NOD SCID mice 58 selective adenosine 58 IGF 1R inhibitor 58 xanthine oxidase inhibitor 58 gemcitabine cisplatin 57 fluticasone propionate FP 57 Liposomal 57 XTEN 57 nasal spray formulation 57 Pegylated Liposomal Doxorubicin 57 antiviral efficacy 57 Alferon N 57 Platinol ® cisplatin 57 PSMA ADC 57 orally dosed 57 plasmid encoding 57 Amplimexon 57 anti angiogenic agent 57 sargramostim 57 pharmacokinetic PK profile 57 Myocardial Perfusion Imaging 57 bortezomib Velcade 56 CorVue ™ 56 paclitaxel Taxol ® 56 FSH CTP 56 HuMax EGFr 56 bevacizumab Avastin R 56 selectively binds 56 octreotide 56 MoxDuo ® 56 Ganciclovir 56 Protelos 56 TH# [003] 56 pegylated IFN 56 GHRH 56 reslizumab 56 Xeloda ® 56 purified protein 56 Hsp# Inhibitor 56 generation purine nucleoside 56 decitabine 56 miconazole Lauriad ® 56 transgene expression 56 DUROS 56 VEGF inhibitor 56 Combination therapy 56 analgesic efficacy 56 Gleevec resistant 56 dasatinib Sprycel 56 Teriflunomide 56 Degarelix 56 beta 1a 56 antiangiogenic agent 56 receptor antagonism 56 solithromycin 56 FOLFOX6 56 naltrexone SR 56 targeted antifolate 56 DEB# 56 MP4OX 56 metastatic malignant 56 Qdot 56 MoxDuo 56 peptide conjugated 55 Dynabeads 55 selective agonist 55 viral kinetics 55 renal artery stenting 55 Microwave Ablation System 55 small molecule tyrosine 55 Dabigatran etexilate 55 ara C 55 Anticalins ® 55 GW# [003] 55 protein tyrosine phosphatase 55 treat benign prostatic 55 antiviral potency 55 Annexin V 55 Tarvacin 55 fluoropyrimidine 55 vapreotide acetate 55 mometasone 55 concurrent chemoradiation 55 L methionine 55 Vaxfectin R 55 Fc fusion protein 55 inhaled iloprost 55 Investigational eFlow 55 Pharmacokinetic studies 55 isosorbide dinitrate 55 intravesical 55 insulin aspart 55 gemcitabine Gemzar 55 PRO# [003] 55 interferon IFN 55 oral rivaroxaban 55 M1 muscarinic 55 Tubulin 55 Catena ® 55 chimeric monoclonal antibody 55 HCl capsules 55 Posaconazole 55 novel oral anticoagulant 55 TGZ 55 HuMax 55 dopamine partial agonist 55 AST ALT 55 paclitaxel Taxol 55 Pharmacokinetics PK 55 administered subcutaneously 55 Nexavar sorafenib tablets 55 trodusquemine 55 Kahalalide F 55 Phase 1b trial 55 ZOLINZA 55 favorable pharmacokinetic profile 55 Novel Inhibitor 55 tenofovir disoproxil fumarate Viread 55 histamine dihydrochloride 55 ficlatuzumab 55 octreotide acetate 55 NanoBridge 55 inhaled treprostinil 55 Medoxomil 55 BoNT 55 TG# [003] 55 paclitaxel poliglumex 55 Panzem R NCD 55 PI3K inhibitor 55 bioabsorbable polymer 55 Bortezomib 55 Q#IR 55 gemtuzumab ozogamicin 55 tumor xenograft models 55 Activity Assay 55 dimeglumine 55 TIMP 1 55 selective A2A adenosine receptor 55 Exenatide Byetta 54 Orally administered 54 lesional 54 Percutaneous Tibial Nerve Stimulation 54 murine monoclonal antibody 54 ANAVEX #-# [001] 54 visilizumab 54 somatostatin analogue 54 FOLFOX6 chemotherapy regimen 54 pramipexole dihydrochloride 54 Factor VIIa 54 VAPRISOL 54 timolol 54 CDK inhibitor 54 Deadlinepix 54 pioglitazone HCl 54 Genz # 54 olmesartan 54 orally inhaled 54 ChronVac C R 54 nimodipine 54 BeneFIX 54 chemotherapy FOLFOX 54 ZD# [001] 54 PROMUS TM 54 bleomycin 54 salmeterol fluticasone 54 antiapoptotic 54 bupropion HCl 54 Thermo Scientific LTQ Orbitrap 54 cefotaxime 54 OvaRex R 54 Tumor Response 54 etoposide 54 selective modulator 54 vinorelbine tartrate 54 Silodosin 54 p# biomarker 54 azacytidine 54 Tasimelteon 54 nanopharmaceutical 54 immunomodulatory therapy 54 CD# CD# 54 Central Venous Catheter 54 microsomal 54 MVA MUC1 IL2 54 1α 54 Non inferiority 54 BRIM2 54 6mg 54 synthetic peptide containing 54 lamivudine zidovudine 54 Peg IFN 54 Discovery Labs aerosolized 54 poloxamer 54 Capesaris 54 EBMT criteria 54 oral salmon calcitonin 54 radiosensitivity 54 HMG CoA reductase inhibitor 54 #F FDG 54 Aeroquin 54 Myelodysplastic Syndrome MDS 54 Isolagen Process 54 syngeneic 54 nucleotide analog 54 morpholino 54 xenograft model 54 proteasome inhibitor bortezomib 54 Pharmacokinetic analyzes 54 5alpha reductase 54 estrogen receptor antagonist 54 relapsed MM 54 LAB CGRP 54 Y# [004] 54 HuMax CD4 54 Cimzia TM 54 beta interferons 54 Intravesical 54 alicaforsen enema 54 sorafenib Nexavar ® 54 IFN α 54 PHASE III 54 triphendiol 54 Estrogen Receptor 54 tricalcium phosphate 54 developing Bicifadine serotonin 54 ACTEMRA TM 54 HCV replicon 54 Epoprostenol 54 intradermal delivery 54 mineralocorticoid receptor 54 Protease Inhibitors 54 darunavir ritonavir 54 OvaRex MAb 54 muscarinic 54 RRM1 54 Darusentan 54 vivo potency 54 GEMS TM 54 Plicera 54 mTOR inhibitors 54 HCV protease inhibitors 54 TGF beta1 54 Reductase 54 Catenin 54 Helixate R 54 AtherOx 54 intranasal delivery 53 oxybutynin 53 plasmid DNA vaccine 53 timolol maleate 53 triiodothyronine 53 ULORIC 53 hepatocellular carcinomas 53 pharmacokinetic PK study 53 Kinoid 53 Vinorelbine 53 latanoprost 53 Attrius 53 r hGH 53 synthase TS 53 aspirin clopidogrel 53 Solorel TM 53 enzyme inhibitor 53 Oral Spray 53 PEGPH# 53 liposome encapsulated 53 RH1 53 liposome formulation 53 oral ridaforolimus 53 immune modulating 53 Clinical Study Shows 53 IFN Beta CTP 53 rhITF 53 abacavir Ziagen 53 XYOTAX TM 53 Dapagliflozin 53 Phase Ib study 53 Galantamine 53 Traficet EN 53 AEGR 53 volociximab 53 replicon 53 TNF alpha inhibitor 53 xenograft models 53 Intrathecal 53 recombinant adeno associated 53 aromatase inhibitor AI 53 Declares Dividend Quick Facts 53 trospium 53 carboxypeptidase 53 ND# [002] 53 fosbretabulin 53 temozolomide Temodar 53 5 FU leucovorin 53 monophasic 53 interleukin IL -# 53 1beta 53 mesalazine 53 mGluR5 antagonist 53 investigational immunotherapy 53 platelet inhibitor 53 immunomodulation 53 ZFP TF 53 CIMZIA TM 53 TRC# 53 Inhaled AAT 53 Adaptive Radiation Therapy 53 nucleoside analog 53 radiochemotherapy 53 Platinol 53 5 HT2C receptor 53 novel emulsion formulation 53 transfection reagent 53 PDE4 inhibitor 53 Surfactant Replacement Therapy 53 estramustine 53 intravenous dosing 53 natriuretic peptide 53 HGS# 53 Recurrent Glioblastoma 53 syngo ® 53 effector function 53 E1 INT TM 53 Polymerase 53 mineralocorticoid 53 ADP receptor antagonist 53 intravesical therapy 53 brivaracetam 53 Arsenic trioxide 53 Spheramine 53 Orally Active 53 ACZ# 53 L PPDS 53 intradermal injections 53 preclinical efficacy 53 radioligand 53 immunostimulant 53 Omacetaxine 53 subcutaneous dosing 53 ribavirin Copegus ® 53 ADAGIO study 53 LEUKINE 53 COPEGUS R 53 receptor tyrosine kinase inhibitor 53 potently inhibits 53 Tyrosine Kinase Inhibitor 53 K ras mutations 53 Rev Dex 53 REMINYL ® 53 antitumour 53 HYLENEX recombinant 53 Medisorb R 53 maximally tolerated 53 ^ Tc 53 TLR agonists 53 OncoVEX 53 Targretin capsules 53 intranasal formulation 53 Pitavastatin 53 idebenone 53 DCCR 53 thalidomide Thalomid 53 trastuzumab Herceptin R 53 SPRIX ® 53 substrate specificity 53 Zenpep 53 phospholipase 53 selective orally bioavailable 53 metformin sulfonylurea 53 Anticalin R 53 everolimus eluting stents 53 UPLYSO 53 PD# [002] 53 Annexin 53 Plasmid DNA 53 Alvesco R 53 CGRP 53 homozygote 53 Certolizumab pegol 53 Phase IIb trials 53 atorvastatin #mg 53 XmAb# 53 Dacogen decitabine 53 Chemoradiation 53 tipranavir r 53 Aurora Kinase 53 Multiple Ascending Dose 52 somatostatin receptor 52 Preclinical studies 52 debulking surgery 52 GLP1 agonist 52 Gastrointestinal Stromal Tumors 52 Watchful Waiting 52 COPAXONE 52 novel nucleoside analog 52 medroxyprogesterone acetate MPA 52 CD# monoclonal antibody 52 selective antagonist 52 clonidine hydrochloride 52 Endarterectomy 52 C#A [002] 52 MAXIMA 52 antiproliferative activity 52 PEGylated Fab fragment 52 dose proportionality 52 intracellular Ca 2 52 lumiliximab 52 Initiate Phase 52 Posiphen 52 AeroLEF TM 52 Anticalin ® 52 trans retinoic acid ATRA 52 salmon calcitonin 52 glucosidase 52 siRNAs targeting 52 antidepressant efficacy 52 allogeneic cell 52 TO AVOID PREGNANCY WHILE 52 phosphorothioate 52 PROMUS Element 52 Pentraxin 2 52 Trofile assay 52 sirolimus eluting stents 52 systemic immunosuppressive drugs 52 thymidine 52 Vidofludimus 52 Immunoassay System 52 deoxy 52 semisynthetic 52 Adrenergic 52 chemotherapeutic drug 52 QuadraSphere 52 non nucleoside 52 pharmacokinetic equivalence 52 JAK2 inhibitor 52 DOXIL 52 Carbidopa 52 adjuvant cisplatin 52 LPS induced 52 IFN beta 52 recurrent glioblastoma 52 TriRima 52 Fenretinide 52 aerosolized KL4 surfactant 52 stavudine d4T 52 Granulocyte Colony Stimulating Factor 52 Chemokine Receptor 52 OptiCell 52 fluticasone furoate 52 drug zotarolimus 52 pharmacokinetic properties 52 Quantitation 52 brand ciclesonide HFA 52 Dual Opioid 52 Phase 1a clinical 52 DP b# 52 pharmacologically active isomer 52 imexon 52 MET inhibitor 52 Diabetic Neuropathy 52 polyglutamate 52 recombinant FVIII 52 oral prodrug 52 lactate dehydrogenase LDH 52 t# c# CLA 52 Protein Kinase C 52 proprietary polysaccharide 52 BrachySil TM 52 lenalidomide dexamethasone 52 DU# [002] 52 ALT elevations 52 immunoglobulin Ig 52 orally disintegrating 52 HyStem 52 CRLX# 52 confirmatory clinical 52 RLY# 52 Phase 2b Trial 52 TASKi3 52 hydroxypropyl 52 Meets Primary Endpoint 52 cystinosis patients 52 Lamotrigine 52 cyanocobalamin 52 Adenosine 52 injectable formulations 52 FXIII 52 Mg Usa 52 SCH # 52 Elitek 52 Guides FY# Quick Facts 52 Benazepril 52 mutational status 52 EBRT 52 proton pump inhibitor PPI 52 Apolipoprotein 52 wilate ® 52 Arisaph 52 DLTs 52 CYT# potent vascular disrupting 52 tinzaparin 52 zotarolimus 52 HCl tablets 52 KING COBRA 52 SANVAR 52 PTHrP 52 Plus STAARVISC TM 52 mediated inhibition 52 Imprime PGG ® 52 dipeptide 52 Antiviral Therapy 52 PET tracers 52 ESBA# 52 doxorubicin docetaxel 52 tumorigenicity 52 induced phosphorylation 52 NNRTI resistant virus 52 thymidylate synthase TS 52 F FLT 52 TUNEL 52 coexpression 52 glycogen synthase 52 carbidopa 52 Multiple Myeloma MM 52 radiation dosimetry 52 DNA methylation markers 52 BMP2 52 tolevamer 52 miglustat 52 Adult Stem Cell Therapy 52 Vascugel R 52 binds selectively 52 Allogeneic 52 targeted radiotherapeutic 52 #ß 52 HALO# [001] 52 db db mice 52 DexaSite 52 annexin V 52 oral transmucosal 52 potent CYP#A# inhibitors 52 antifolates 52 bortezomib Velcade R 52 ® bortezomib 52 adrenoceptor 52 ibandronate 52 canakinumab 52 osteoinductive 51 TLK# 51 GDIR 51 convenient dosing regimens 51 Humate P 51 ACUROX ® 51 Endovascular System 51 FOLPI 51 annexin 51 Soliris eculizumab 51 demethylating agent 51 Demonstrates Potential 51 nanomolar range 51 preclinically 51 antiangiogenic activity 51 TPMT 51 Xelox 51 Achieves Primary Endpoint 51 hematological parameters 51 M#V 51 potent cytotoxic 51 sd rxRNA 51 Retisert 51 Technosphere ® 51 Initiate Clinical Trial 51 HCl Injection 51 Antiviral Activity 51 prostate carcinoma 51 phenelzine 51 biochemical relapse 51 ACUROX 51 topical gel formulation 51 dose dependently 51 oblimersen 51 HuCAL antibodies 51 Oxybutynin 51 temsirolimus Torisel ® 51 Gets FDA Clearance 51 ReFacto 51 baseline LDH 51 Vaxfectin TM 51 null mice 51 single injection viscosupplement 51 Schottky rectifiers 51 dose dexamethasone 51 D#A [002] 51 EGFR HER2 51 MoxDuo R 51 CIMZIA ™ 51 NanoEmulsion 51 Spiegelmer ® 51 omega interferon 51 SURFAXIN r 51 glutamyl 51 sitaxsentan 51 Solulin 51 multidetector row 51 BioMatrix TM 51 proprietary chemically modified 51 ® natalizumab 51 HSP# inhibitor 51 prostatic tissue 51 CsA 51 TransVax tm 51 Leydig cell 51 IL#B 51 imatinib therapy 51 tegafur 51 Delcath PHP System 51 Cimzia ® certolizumab pegol 51 thioester 51 idarubicin 51 RT PCR assay 51 CD8 + cytotoxic 51 Tyrosine Kinase 51 MultiWave 51 peripherally acting 51 rHuPH# enzyme 51 lenalidomide Revlimid ® 51 Letairis ambrisentan 51 VSV G 51 Prolactin 51 Cardiac Troponin 51 zileuton 51 mimetic peptide 51 phosphatidylserine PS 51 pharmacodynamics PD 51 CRp 51 inhalation powder 51 Vaprisol 51 beta lactam antibiotic 51 virological response 51 myeloproliferative 51 Receptor Antagonists 51 apolipoproteins 51 vasodilatory 51 oral levofloxacin 51 Remission Maintenance 51 INT# [002] 51 M8 M# 51 NanoTab 51 Enkephalin 51 metered dose inhaler MDI 51 fluorodeoxyglucose 51 #DF [001] 51 mertansine 51 peak plasma concentrations 51 cannabinor 51 BIO SET 51 Seeplex 51 DB# [003] 51 receptor agonist 51 phorbol 51 Benephit 51 Gly 51 Trofex 51 cisplatin gemcitabine 51 anti leukemic 51 demonstrated clinically meaningful 51 Tumor Necrosis Factor 51 Nucleic Acid Test 51 ACTOS ® 51 Diabetic Foot Ulcer 51 FOLFOX chemotherapy 51 antisense inhibition 51 Dyloject TM 51 DepoVax 51 Firazyr 51 SYNAPT G2 51 CCR5 receptor antagonist 51 EP# [003] 51 RhuDex ™ 51 HIV coinfected 51 azilsartan medoxomil plus 51 capsular polysaccharide 51 systemic hypotension 51 hA# 51 NAVISTAR R 51 PERLANE L 51 peptidomimetic 51 NasalFent 51 vascular disrupting agent 51 novel synthetic peptide 51 nucleoside nucleotide 51 Anticalins R 51 glucocorticoid induced 51 investigational antiplatelet 51 thymidine kinase 51 irbesartan 51 oxaliplatin Eloxatin 51 FUSILEV enhances 51 transduced 51 Vaxfectin 51 Technosphere Insulin 51 mTOR mammalian target 51 phosphorylase 51 Investigational eFlow Nebulizer System 51 TAKSTA 51 somatostatin 51 TRUS 51 topical formulation 51 SERCA2a 51 SSc 51 PSN# [001] 51 RONDEL 51 LB# [003] 51 Pharmacokinetic parameters 51 endothelin antagonists 51 NUVIGIL ® 51 biliary tract cancer 51 potentiator 51 Bicalutamide 51 fludarabine cyclophosphamide 51 GAMMAGARD 51 Therapy Reduces 51 ganaxolone 51 MBq 51 Florbetapir 51 Desorption 51 MoxDuo TM IR 51 cetuximab Erbitux ® 51 P2X 51 electrosurgical generator 51 interferon γ 51 amikacin 51 probiotic Lactobacillus 51 Lucentis ranibizumab Genentech 51 metformin XR 51 isomerase 51 humanized anti 51 UNI XC 51 AGHD 51 epithelial sodium 51 ADAMTS# 51 anti angiogenic agents 51 nanomolar 51 Phase Ib II 51 HepDirect prodrug 51 VISICOL R 51 Perforomist ™ Inhalation Solution 51 balsalazide disodium 51 GLP1 51 agonist LABA 51 Ophena 51 hyaluronidase enzyme 51 Cefazolin 51 Resten NG 51 A2A receptor 51 proteolytic degradation 51 ENMD # 51 ProSafe RS 51 MU# [002] 51 ReN# 51 TroVax ® 51 2 methoxyestradiol #ME# 51 Aeolus Pharmaceuticals Announces 51 malignant ascites 51 functional mitral regurgitation 51 deforolimus 51 Chemophase 51 Epirubicin 51 Tekamlo 51 AnaSpec Introduces 51 postoperative chemotherapy 51 cediranib 51 Lanthanum carbonate 51 receptor antagonists 51 TELINTRA 51 variant allele 51 TEL AML1 51 Inhalation Solution 51 Dural Regeneration Matrix 51 isoproterenol 51 mg/m2 cohort 51 pDC 51 Potent Inhibitor 51 EGFP 51 Shellgel TM injectable viscoelastic 51 antifibrotic 51 Transdermal Patch 50 gene polymorphism 50 Phase IIb Clinical Trial 50 Lubiprostone 50 TriGrid ™ 50 CC genotype 50 Aerosurf 50 CRMD# 50 lipopolysaccharide LPS 50 radiolabeled 50 Ataluren 50 isoform selective 50 Histologic 50 biomarker assay 50 isogenic 50 cytokine refractory 50 Capsules USP 50 PrandiMet TM 50 T#/T# 50 PTI CORR 50 Phase IIb clinical trials 50 PROSTVAC ® 50 beta3 50 Levoleucovorin 50 CytoSorb 50 selectively inhibited 50 apomorphine hydrochloride 50 decarboxylase 50 radioprotective 50 MAINTAINS BUY 50 DCVax Brain 50 Pegylated interferon 50 Double Blind Randomized 50 ibritumomab tiuxetan 50 Loss Severity Rating 50 hydrochlorothiazide tablets 50 bioavailable testosterone 50 ALVESCO ® 50 carboxy terminal 50 T#C [003] 50 Trobalt 50 neoadjuvant treatment 50 Sitrans 50 Platelet Rich Plasma PRP 50 homozygotes 50 elvucitabine 50 irinotecan doxorubicin oxaliplatin paclitaxel 50 Bicifadine 50 aerosol formulation 50 Phase #b/#a clinical 50 #Y ibritumomab tiuxetan 50 alpha2 50 Guides FY# Update 50 Akt activation 50 Cardiotoxicity 50 Methylin 50 Otelixizumab 50 labetuzumab 50 Anti VEGF 50 potentially hepatotoxic 50 potency selectivity 50 5-fluorouracil/leucovorin 50 Terbinafine 50 hPTH #-# 50 immunoreactive 50 act synergistically 50 colorectal adenoma 50 Antiangiogenic 50 NanoCrystal Technology 50 INCERT R 50 recombinant soluble 50 lactate dehydrogenase 50 O PPDS 50 transurethral 50 mutated K ras 50 CAPHOSOL 50 interferon beta therapy 50 anticancer activity 50 hyperplasia BPH 50 targeting moieties 50 OROS 50 receptor blockers 50 multitargeted 50 gastric adenocarcinoma 50 A#V 50 HOXB# 50 plus COPEGUS 50 relaxivity 50 Transdermal Delivery 50 GSTP1 50 sulfonylurea glimepiride 50 Vidaza ® 50 cytotoxicity 50 selective inhibition 50 aldehyde dehydrogenase ALDH2 deficiency 50 TOF TOF 50 Zemplar Capsules 50 Cardiorespiratory fitness 50 IPLEX 50 μg ml 50 Phase III confirmatory 50 cromolyn sodium 50 durable remissions 50 IL 1ß 50 symptomatic paroxysmal AF 50 Hexvix ® 50 pulmonary exacerbations 50 intact parathyroid hormone 50 #I [003] 50 epoetin alfa 50 microdose 50 fallopian tube cancers 50 TM Embolic Protection 50 immunosuppressives 50 ligand induced 50 IIIa inhibitor 50 sonographically 50 PN# [001] 50 propafenone 50 Avastin Tarceva 50 Loxapine 50 VIDAZA ® 50 locoregional 50 Cyanokit R 50 allelic variants 50 GnRH antagonist 50 immunofluorescence microscopy 50 OMS# 50 ruxolitinib 50 standard chemotherapy regimens 50 stably transfected 50 FDG uptake 50 glycopeptide 50 phosphoprotein 50 PU.1 50 anticancer treatments 50 Medicsight ColonCAD 50 pharmacokinetics PK 50 Imatinib mesylate 50 NOD mouse 50 antiproliferative 50 HQK 50 indibulin 50 REMUNE R 50 BALF 50 adenosine diphosphate ADP 50 α β 50 Pennsaid R 50 Escitalopram 50 Receptor Antagonist 50 flecainide 50 Lower Limb 50 lispro 50 capillary leak 50 ^ sup #m 50 Schizophrenia Treatment 50 cardiac perfusion 50 adenosine injection 50 GORE TAG Device 50 benign prostatic hypertrophy BPH 50 Plaque Psoriasis 50 plasma pharmacokinetics 50 Kinase Inhibitor 50 successfully commercialize Iluvien 50 VEGF receptor 50 NK1 50 RT# [002] 50 lysophosphatidic acid 50 Ofloxacin 50 bioresorbable stent 50 Cetuximab Erbitux 50 cyclophosphamide doxorubicin vincristine 50 ß2 50 FDG PET imaging 50 pharmacokinetic interactions 50 SOCS3 50 Cinacalcet 50 Comparators 50 V3D Colon 50 eTag assays 50 Zilver PTX stent 50 QVAR 50 antiangiogenic agents 50 constitutively active 50 Emezine 50 Illumina Solexa 50 Fracture Intervention Trial 50 cytotoxic T lymphocyte 50 EDEMA3 50 immunoreactivity 50 hydroxamic acid 50 circadian cytokine modulator 50 K#N 50 HMG CoA reductase inhibitors